Has iHerb produced a public copy of any termination or separation agreement with Dr. Oz, and where to find it?

1. Public claims versus public documents: what the reporting actually shows

Multiple news outlets and company statements record that Dr. Oz “is no longer affiliated with iHerb” and that a termination agreement was “executed” (iHerb/PEOPLE, Yahoo/Lead Stories, Newsweek) but those items are characterizations and press statements rather than publication of a termination or separation agreement document by iHerb itself ^{[1] [2] [4]}. The New York Times and other outlets report that Oz later reported selling his iHerb stock in a disclosure form, and that iHerb said publicly it is no longer affiliated with Oz ^{[5] [4]}.

2. The clearest primary public filing is Oz’s ethics amendment, not an iHerb contract

The most concrete primary record in the supplied reporting is Dr. Oz’s amended ethics agreement filed with the Office of Government Ethics, which states he will resign positions with iHerb-related entities and divest holdings and was posted publicly as part of his ethics disclosures ^[3]. That OGE filing is a government ethics document authored or filed by Oz and his team; it is not a copy of a private termination or separation agreement issued by iHerb to Oz, and the reporting does not claim that it is.

3. Congressional correspondence and watchdog scrutiny reference termination language but don’t produce the agreement

Sen. Elizabeth Warren’s letter and watchdog reporting cite language about termination/suspension of an “Advisor Agreement” and note retained interests in certain entities, but those materials quote or interpret agreements rather than attach an iHerb-produced separation contract for public download ^[6]. Likewise, press reports about promotional posts, divestment pledges, and potential FTC interest document the context of the split without reproducing an iHerb termination document ^{[7] [8]}.

4. Where to look — the best public leads in the reporting

For readers seeking primary documents, the OGE ethics amendment for Dr. Oz is publicly posted and cited in reporting as the formal ethics filing describing resignations and divestment commitments ^[3]. For corporate confirmation and contemporaneous statements, major outlets citing iHerb or company spokespeople include People, Newsweek, Yahoo/Lead Stories and the New York Times, which carry iHerb’s statements that Oz “no longer has any affiliation” and reporting that Oz sold stock ^{[2] [4] [1] [5]}. None of those sources, however, include a link to a termination or separation agreement released by iHerb itself.

5. Alternative explanations and institutional incentives

Two plausible explanations fit the record: iHerb may have executed a private termination agreement and chosen not to publish it, while public confirmation came via company statements and Oz’s own ethics filings ^{[1] [3]}; alternatively, the parties may have memorialized the separation within internal documents and relied on public statements instead of releasing contract text. The reporting does not provide evidence one way or the other because no iHerb-produced separation contract appears in the cited sources ^{[1] [4]}.

6. Bottom line — definitive answer based on available reporting

Based on the supplied reporting, there is no public copy of a termination or separation agreement with Dr. Oz produced by iHerb available in the cited sources; the public record accessible here consists of iHerb and media statements about the separation and Oz’s own publicly posted ethics amendment and disclosures, which are the nearest available primary documents ^{[1] [2] [3] [5]}. If an iHerb-issued termination agreement has been released outside these sources, it is not present in the reporting provided.